猴痘的流行病学特征及其科学防控

吴俣; 刘珏; 刘民; 梁万年

doi:10.16462/j.cnki.zhjbkz.2022.09.002

猴痘的流行病学特征及其科学防控

doi: 10.16462/j.cnki.zhjbkz.2022.09.002

吴俣¹,
刘珏¹,
刘民^1, ,,
梁万年^2, ,

1.
100191 北京，北京大学公共卫生学院流行病与卫生统计学系
2.
100084 北京，清华大学万科公共卫生与健康学院

基金项目:

国家重点研发计划 2021ZD0114104

国家重点研发计划 2021ZD0114105

国家重点研发计划 2021ZD0114101

国家自然科学基金 71934002

国家自然科学基金 72122001

详细信息

通讯作者:
梁万年，E-mail: liangwn@tsinghua.edu.cn

刘民，E-mail: liumin@bjmu.edu.cn

中图分类号: R373.1
计量
- 文章访问数: 723
- HTML全文浏览量: 303
- PDF下载量: 143
- 被引次数: 0
出版历程
- 收稿日期: 2022-06-09
- 修回日期: 2022-06-14
- 网络出版日期: 2022-09-17
- 刊出日期: 2022-09-10

Epidemiologic features and scientific prevention and control of monkeypox

WU Yu¹,
LIU Jue¹,
LIU Min^{1
, ,},
LIANG Wan-nian^{2
, ,}

1.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
2.
Vanke School of Public Health, Tsinghua University, Beijing 100084, China

Funds:

National Key Research and Development Project of China 2021ZD0114104

National Key Research and Development Project of China 2021ZD0114105

National Key Research and Development Project of China 2021ZD0114101

National Natural Science Foundation of China 71934002

National Natural Science Foundation of China 72122001

More Information

Corresponding author: LIU Min, E-mail: liumin@bjmu.edu.cn; LIANG Wan-nian, E-mail: liangwn@tsinghua.edu.cn

摘要

摘要: 猴痘是由猴痘病毒(monkeypox virus, MPXV)引起的一种罕见的、散发的、天花样临床表现的急性传染病。2022年5月以来，全球报告了超过1 000例猴痘实验室确诊病例，这是全球首次猴痘非流行国家和流行国家同时报告了多个猴痘病例和聚集性病例，对全球猴痘疫情的防控提出了新挑战。本文就猴痘的病原学特征、流行现状、流行病学特征、防控措施等方面的研究进展进行综述，以期为科学防控提供参考。
- 猴痘 /
- 流行病学特征 /
- 防控措施
Abstract: Monkeypox is a rare, sporadic, acute infectious disease with smallpox-like clinical manifestations caused by monkeypox virus (MPXV). Since May 2022, more than 1 000 laboratory-confirmed cases of monkeypox have been reported worldwide. This is the first time in the world that multiple monkeypox cases and clustered cases have been reported in both non-endemic and endemic countries. The prevention and control of the epidemic presents new challenges. This study reviewed the research progress on the etiological characteristics, epidemic status, epidemiological characteristics, and prevention and control measures of monkeypox virus, in order to provide reference for scientific prevention and control.
- Monkeypox /
- Epidemiological characteristics /
- Prevention and control measures

HTML全文

参考文献(19)

[1]	WHO. Monkeypox[EB/OL]. (2022-05-19)[2022-06-08]. https://www.who.int/news-room/fact-sheets/detail/monkeypox.
[2]	Centers for Disease Control and Prevention. 2022 monkeypox and orthopoxvirus outbreak global map[EB/OL]. (2022-06-07)[2022-06-08]. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html.
[3]	WHO. Multi-country monkeypox outbreak: situation update[EB/OL]. (2022-06-04)[2022-06-08]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON390.
[4]	Alakunle E, Moens U, Nchinda G, et al. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution[J]. Viruses, 2020, 12(11): 1257. DOI: 10.3390/v12111257.
[5]	Shchelkunov SN, Totmenin AV, Safronov PF, et al. Analysis of the monkeypox virus genome[J]. Virology, 2002, 297(2): 172-194. DOI: 10.1006/viro.2002.1446.
[6]	Magnus PV, Andersen EK, Petersen KB, et al. A Pox-like disease in Cynomolgus monkeys[J]. Acta Pathologica Microbiologica Scandinavica, 1959, 46(2): 156-176.
[7]	Marennikova SS, Seluhina EM, Mal'ceva NN, et al. Poxviruses isolated from clinically ill and asymptomatically infected monkeys and a chimpanzee[J]. Bull World Health Organ, 1972, 46(5): 613-620. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480788/
[8]	Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy[J]. PLoS Negl Trop Dis, 2019, 13(10): e0007791. DOI: 10.1371/journal.pntd.0007791.
[9]	Damon IK, Roth CE, Chowdhary V. Discovery of monkeypox in Sudan[J]. N Engl J Med, 2006, 355(9): 962-963. DOI: 10.1056/NEJMc060792.
[10]	Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature[J]. Lancet, 1986, 1(8472): 98-99. DOI: 10.1016/s0140-6736(86)90748-8.
[11]	Radonic' A, Metzger S, Dabrowski PW, et al. Fatal monkeypox in wild-living sooty mangabey, Côte d'Ivoire, 2012[J]. Emerg Infect Dis, 2014, 20(6): 1009-1011. DOI: 10.3201/eid2006.13-1329.
[12]	Patrono LV, Pléh K, Samuni L, et al. Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity[J]. Nat Microbiol, 2020, 5(7): 955-965. DOI: 10.1038/s41564-020-0706-0.
[13]	Berthet N, Descorps-Declère S, Besombes C, et al. Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018[J]. Sci Rep, 2021, 11(1): 13085. DOI: 10.1038/s41598-021-92315-8.
[14]	张睿, 陈国强, 张敬友, 等. 猴痘研究进展[J]. 中国动物检疫, 2011, 28(9): 71-73. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGDW201109034.htm Zhang R, Chen GQ, Zhang JY, et al. Advances in monkeypox research[J]. China Animal Health Inspection, 2011, 28(9): 71-73. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGDW201109034.htm
[15]	Antinori A, Mazzotta V, Vita S, et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022[J]. Euro Surveill, 2022, 27(22): 2200421. DOI: 10.2807/1560-7917.ES.2022.27.22.2200421.
[16]	Perez Duque M, Ribeiro S, Martins JV, et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022[J]. Euro Surveill, 2022, 27(22): 2200424. DOI: 10.2807/1560-7917.ES.2022.27.22.2200424.
[17]	Vivancos R, Anderson C, Blomquist P, et al. Community transmission of monkeypox in the United Kingdom, April to May 2022[J]. Euro Surveill, 2022, 27(22): 2200422. DOI: 10.2807/1560-7917.ES.2022.27.22.2200422.
[18]	Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK[J]. Lancet Infect Dis, 2022, 22(8): 1153-1162. DOI: 10.1016/S1473-3099(22)00228-6.
[19]	Kozlov M. Monkeypox goes global: why scientists are on alert[J]. Nature, 2022, 606(7912): 15-16. DOI: 10.1038/d41586-022-01421-8.